Top

26-11-2024

Understanding diagnostic delays and health outcomes for inflammatory bowel disease: a mixed-methods study of patients’ perspectives

Auteurs: R. J. Purc-Stephenson, Keely Blake

Gepubliceerd in: Quality of Life Research

Abstract

Purpose

Inflammatory bowel disease (IBD) is a chronic condition affecting the digestive system with symptoms that are often episodic, unpredictable, socially stigmatizing, and impact quality of life. While a timely diagnosis reduces the risk of complications and improves health outcomes, diagnostic delays (DDs) are common. Our study used narratives and data from patient-reported outcome measures (PROMs) of individuals diagnosed with IBD to examine: (1) What factors helped or hindered achieving a timely diagnosis of IBD? and (2) how do DDs relate to PROMs?

Methods

We conducted a mixed-methods study of 296 individuals diagnosed with IBD in Canada. The survey included a set of validated measures that assessed depression, fatigue, satisfaction with life, disease severity, and several open-ended questions.

Results

Thematic analysis of open-ended responses revealed five themes that highlighted the ways a diagnosis was delayed or facilitated: symptom ambiguity, fear and denial, patient-provider communication breakdown, misdiagnosis and self-doubt, and self-advocacy. Quantitative findings revealed that a longer time to receive a diagnosis was significantly correlated with higher levels of depression (r = .26) and fatigue (r = .25), reduced satisfaction with life (r = − .25), and greater disease severity (r = − .22). We used the data to generate a framework called the Diagnostic Pathways Model to illustrate the diagnostic process of a chronic disease such as IBD.

Conclusion

DDs involve the interacting roles of patient, medical, and communication factors, and a DD can negatively impact a patient’s quality of life. Implications for physician–patient communication and public information are discussed.

Alleen toegankelijk voor geautoriseerde gebruikers

Crohn’s and Colitis Canada (2019). What are Crohn’s and Colitis? https://crohnsandcolitis.ca/About-Crohn-s-Colitis/What-are-Crohns-and-Colitis

Benchimol, E. I., Mauel, D. G., Guttmann, A., Nguyen, G. C., Mojaverian, N., Quach, P., & Mack, D. R. (2014). Changing age demographics of inflammatory bowel disease in Ontario, Canada: A population-based cohort study of epidemiology trends. Inflammatory Bowel Diseases, 20(10), 1761–1769. https://doi.org/10.1097/MIB.0000000000000103CrossRefPubMed

Frolkis, A. D., Dykeman, J., Negrón, M. E., deBruyn, J., Jette, N., Fiest, K. M., Frolkis, T., Barkema, H. W., Rioux, K., Panaccione, R., Gosh, S., Wiebe, S., & Kaplan, G. (2013). Risk of surgery for inflammatory bowel diseases has decreased over time: A systematic review and meta-analysis of population-based studies. Gastroenterology, 145(5), 996–1006. https://doi.org/10.1053/j.gastro.2013.07.041CrossRefPubMed

Stidham, R., & Higgins, P. D. (2018). Translational research in colorectal cancer: Colorectal cancer in inflammatory bowel disease. Clinics in Colon and Rectal Surgery, 31(3), 168–178. https://doi.org/10.1055/s-0037-1602237CrossRefPubMed

Jordan, C., Ohlsen, R., Hayee, B., & Chalder, T. (2018). A qualitative study exploring the experience of people with IBD and elevated symptoms of anxiety and low mood and the type of psychological help they would like. Psychology & Health, 33(5), 634–651. https://doi.org/10.1080/08870446.2017.1381958CrossRef

Qualter, P., Rouncefield-Swales, A., Bray, L., Blake, L., Allen, S., Probert, C., Crook, K., & Carter, B. (2021). Depression, anxiety, and loneliness among adolescents and young adults with IBD in the UK: The role of disease severity, age of onset, and embarrassment of the condition. Quality of Life Research, 30, 497–506. https://doi.org/10.1007/s11136-020-02653-9CrossRefPubMed

Kaplan, G., Bernstein, C. N., Coward, S., Bitton, A., Murthy, S., Nguyen, G., Lee, K., Cooke-Lauder, J., & Benchimol, E. (2019). The impact of inflammatory bowel disease in Canada, 2018. Journal of the Canadian Association of Gastroenterology, 2, s6–s16. https://doi.org/10.1093/jcag/gwy054CrossRefPubMed

Maconi, G., Orlandi, L., Asthana, A. K., Sciurti, R., Furfaro, F., Bazzio, C., & de Franchis, R. (2015). The impact of symptoms, irritable bowel syndrome pattern and diagnostic investigations on the diagnostic delay of Crohn’s disease: A prospective study. Digestive and Liver Disease, 47(8), 646–651. https://doi.org/10.1016/j.dld.2015.04.009CrossRefPubMed

Walker, G., Lin, S., Chanchlani, N., Thomas, A., Hendy, P., Heerasing, N., Moore, L., Green, H. D., Chee, D., Bewshea, C., Mays, J., Kennedy, N., Ahmad, T., & Goodhand, J. (2020). Quality improvement project identifies factors associated with delay in IBD diagnosis. Alimentary Pharmacology & Therapeutics, 52(3), 471–480. https://doi.org/10.1111/apt.15885CrossRef

10.

Lee, D., Koo, J. S., Choe, J. W., Suh, S. J., Kim, S. Y., Hyun, J. J., Jung, S. W., Jung, Y. K., Yim, H. J., & Lee, S. W. (2017). Diagnostic delay in inflammatory bowel disease increases the risk of intestinal surgery. World Journal of Gastroenterology, 23, 6474–6481. https://doi.org/10.3748/wjg.v23.i35.6474CrossRefPubMed

11.

Knowles, S. R., Graff, L. A., Wilding, H., Hewitt, C., Keefer, L., & Mikocka-Walus, A. (2018). Quality of life in inflammatory bowel disease: A systematic review and meta-analyses. Inflammatory Bowel Diseases, 24(4), 742–751. https://doi.org/10.1093/ibd/izx100CrossRefPubMed

12.

Avery, P. (2021). Using e-health tools and PROMs to support self-management in patients with inflammatory bowel disease. British Journal of Nursing, 30(7), 394–402. https://doi.org/10.12968/bjon.2021.30.7.394CrossRefPubMed

13.

Gamwell, K., Baudino, M., Bakula, D., Sharkey, C., Roberts, C., Grunow, J., Jacobs, N., Gillaspy, S., Mullins, L., & Chaney, J. M. (2018). Perceived illness stigma, thwarted belongingness, and depressive symptoms in youth with inflammatory bowel disease (IBD). Inflammatory Bowel Diseases, 24(5), 960–965. https://doi.org/10.1093/ibd/izy011CrossRefPubMed

14.

Robinson, J. D. (2003). An international structure of medical activities during acute visits and its implications for patients’ participation. Health Communication, 15(1), 27–59. https://doi.org/10.1207/S15327027HC1501_2CrossRefPubMed

15.

Dumit, J. (2006). Illnesses you have to fight to get: Facts as forces in uncertain, emergent illness. Social Science & Medicine, 62, 577–590. https://doi.org/10.1016/j.socscimed.2005.06018CrossRef

16.

Heritage, J., & McArthur, A. (2019). The diagnostic moment: A study in US primary care. Social Science and Medicine, 228, 262–271. https://doi.org/10.1016/j.socscimed.2019.03022CrossRefPubMed

17.

Price, E., & Walker, E. (2014). Diagnostic vertigo: The journey to diagnosis in systemic lupus erythematosus. Health, 18(3), 223–239. https://doi.org/10.1177/1363459313488008CrossRefPubMed

18.

Pedersen, L. H., Wahlberg, A., Cordt, M., Schmiegelow, K., Dalton, S. O., & Larsen, H. B. (2020). Parent’s perspectives of the pathway to diagnosis of childhood cancer: A matter of diagnostic triage. BMC Health Services Research, 20, 1–12. https://doi.org/10.1186/s12913-020-05821-2CrossRef

19.

AWARE-IBD Diagnostic Delay Working Group. (2024). Sources of diagnostic delay for people with Crohn’s disease and ulcerative colitis: Qualitative research study. PLoS ONE, 19(6), e0301672. https://doi.org/10.1371/journal.pone.0301672CrossRef

20.

Oberoi, D., Jiwa, M., McManus, A., & Hodder, R. (2015). Men’s help-seeking behaviour with regards to lower bowel symptoms. American Journal of Health Behaviour, 39(2), 211–220. https://doi.org/10.1111/ecc.12271CrossRef

21.

Taft, T. H., & Keefer, L. (2016). A systematic review of disease-related stigmatization in patients living with inflammatory bowel disease. Clinical and Experimental Gastroenterology, 9, 49–58. https://doi.org/10.2147/CEG.S83533CrossRefPubMed

22.

Lai, C., Sceats, L. A., Qiu, W., Park, K. T., Morris, A. M., & Kin, C. (2019). Patient decision-making in severe inflammatory bowel disease: The need for improved communication of treatment options and preferences. Colorectal Disease, 21(12), 1406–1414. https://doi.org/10.1111/codi.14759CrossRefPubMed

23.

Rubin, D. T., Dubinsky, M. C., Martino, S., Hewett, K. A., & Panés, J. (2017). Communication between physicians and patients with ulcerative colitis: Reflections and insights from a qualitative study of in-office patient–physician visits. Inflammatory Bowel Diseases, 23(4), 494–501. https://doi.org/10.1097/MIB.0000000000001048CrossRefPubMed

24.

Kornelsen, J., Atkins, C., Brownell, K., & Woollard, R. (2016). The meaning of patient experiences of medically unexplained physical symptoms. Qualitative Health Research, 26(3), 367–376. https://doi.org/10.1177/1049732314566326CrossRefPubMed

25.

Su, C. G., Judge, A. T., & Lichtenstein, G. R. (2002). Extraintestinal manifestations of inflammatory bowel disease. Gastroenterology Clinics of North America, 31(1), 307–327. https://doi.org/10.1016/s0889-8553(01)00019-xCrossRefPubMed

26.

Jutel, A., & Nettleton, S. (2011). Towards a sociology of diagnosis: Reflections and opportunities. Social Science & Medicine, 73(6), 793–800. https://doi.org/10.1016/j.socscimed.2011.07.014CrossRef

27.

Nettleton, S., Kitzinger, J., & Kitzinger, C. (2014). A diagnostic illusory? The case of distinguishing between “vegetative” and “minimally conscious” states. Social Science & Medicine, 116, 134–141. https://doi.org/10.1016/j.socscimed.2014.06.036CrossRef

28.

Ayers, S. L., & Kronenfeld, J. J. (2007). Chronic illness and health-seeking information on the Internet. Health: An Interdisciplinary Journal for the Social Study of Health, Illness and Medicine, 11(3), 327–347. https://doi.org/10.1177/1363459307077547CrossRef

29.

Nettleton, S., & Burrows, R. (2003). E-scaped medicine? Information, reflexivity and health. Critical Social Policy, 23, 165–185. https://doi.org/10.1177/026101830302300200CrossRef

30.

Bottomley, A., Reijneveld, J. C., Koller, M., Flechtner, H., Tomaszewski, K. A., Greimel, E., Ganz, P. A., Ringash, J., O’connor, D., Kluetz, P. G., Tafuri, G., & van de Poll-Franse, L. (2019). Current state of quality of life and patient-reported outcomes research. European Journal of Cancer, 121, 55–63. https://doi.org/10.1016/j.ejca.2019.08.016CrossRefPubMed

31.

Williet, N., Sandborn, W. J., & Peyrin-Biroulet, L. (2014). Patient-reported outcomes as primary end points in clinical trials of inflammatory bowel disease. Clinical Gastroenterology and Hepatology, 12(8), 1246–1256. https://doi.org/10.1016/j.cgh.2014.02.016CrossRefPubMed

32.

Singh, S. (2018). PROMises made, PROMises to be kept: Patient-reported outcome measures in inflammatory bowel diseases. Clinical Gastroenterology and Hepatology, 16(5), 624–626. https://doi.org/10.1016/j.cgh.2018.01.032CrossRefPubMed

33.

de Jong, M. J., Huibregtse, R., Masclee, A. A., Jonkers, D. M., & Pierik, M. J. (2018). Patient-reported outcome measures for use in clinical trials and clinical practice in inflammatory bowel diseases: A systematic review. Clinical Gastroenterology and Hepatology, 16(5), 648–663. https://doi.org/10.1016/j.cgh.2017.10.019CrossRefPubMed

34.

Barberio, B., Zamani, M., Black, C. J., Savarino, E. V., & Ford, A. C. (2021). Prevalence of symptoms of anxiety and depression in patients with inflammatory bowel disease: A systematic review and meta-analysis. The Lancet Gastroenterology & Hepatology, 6(5), 359–370. https://doi.org/10.1016/s2468-1253(21)00014-5CrossRef

35.

Borren, N. Z., van der Woude, C. J., & Ananthakrishnan, A. N. (2019). Fatigue in IBD: Epidemiology, pathophysiology and management. Nature Reviews Gastroenterology & Hepatology, 16(4), 247–259. https://doi.org/10.1038/s41575-018-0091-9CrossRef

36.

Hart, A. L., Lomer, M., Verjee, A., Kemp, K., Faiz, O., Daly, A., Solomon, J., & McLaughlin, J. (2017). What are the top 10 research questions in the treatment of inflammatory bowel disease? A priority setting partnership with the James Lind alliance. Journal of Crohn’s and Colitis, 11(2), 204–211. https://doi.org/10.1093/ecco-jcc/jjw144CrossRefPubMed

37.

Rowse, G., Hollobone, S., Afhim, S., & Oliver, P. (2019). DOP30 Factors associated with life satisfaction in people with Crohn’s disease and ulcerative colitis: Results from the national 2018 Crohn’s and Colitis UK Inflammatory Bowel Disease Quality of Life Survey. Journal of Crohn’s and Colitis, 13(Supplement 1), S042–S043. https://doi.org/10.1093/ecco-jcc/jjy222.064CrossRef

38.

van Deen, W. K., Esrailian, E., & Hommes, D. W. (2015). Value-based health care for inflammatory bowel diseases. Journal of Crohn’s and Colitis, 9(5), 421–427. https://doi.org/10.1093/ecco-jcc/jjv036CrossRefPubMed

39.

Creswell, J. W. (2003). Research design: Qualitative, quantitative, and mixed methods approaches (2nd ed.). Sage Publications.

40.

Salmons, J. (2014). Qualitative online interviews: Strategies, design, and skills. Sage Publications.CrossRef

41.

Von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., & Vandenbroucke, J. P. (2007). The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies. The Lancet, 370(9596), 1453–1457.CrossRef

42.

Radloff, L. S. (1977). The CES-D scale: A self-report depression scale for research in the general population. Applied Psychological Measurement, 1(3), 385–401. https://doi.org/10.1177/014662167700100306CrossRef

43.

Miller, W. C., Anton, H. A., & Townson, A. F. (2008). Measurement properties of the CESD scale among individuals with spinal cord injury. Spinal Cord, 46, 287–292. https://doi.org/10.1038/sj.sc.3102127CrossRefPubMed

44.

Hays, R. D., Sherbourne, C. D., & Mazel, R. M. (1993). The rand 36-item health survey 1.0. Health Economics, 2(3), 217–227. https://doi.org/10.1002/hec.4730020305CrossRefPubMed

45.

Irvine, E. J., Zhou, Q., & Thompson, A. K. (1996). The Short Inflammatory Bowel Disease Questionnaire: A quality of life instrument for community physicians managing inflammatory bowel disease. American Journal of Gastroenterology, 91(8), 1571–1578.PubMed

46.

Diener, E. D., Emmons, R. A., Larsen, R. J., & Griffin, S. (1985). The satisfaction with life scale. Journal of Personality Assessment, 49(1), 71–75. https://doi.org/10.1207/s15327752jpa4901_13CrossRefPubMed

47.

Faul, F., Erdfelder, E., Lang, A. G., & Buchner, A. (2007). G* Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behavior Research Methods, 39(2), 175–191.CrossRefPubMed

48.

Colaizzi, R. (1978). Psychological research as the phenomenologist views it. In R. Vale & M. King (Eds.), Existential-phenomenological alternatives for psychology (pp. 48–71). Oxford University Press.

49.

Tufford, L., & Newman, P. (2012). Bracketing in qualitative research. Qualitative Social Work, 11(1), 80–96. https://doi.org/10.1177/1473325010368316CrossRef

50.

McCormick, J. B., Hammer, R. R., Farrell, R. M., Geller, G., James, K. M., Loftus, E. V., Mercer, M. B., Tilburt, J. C., & Sharp, R. R. (2012). Experiences of patients with chronic gastrointestinal conditions: In their own words. Health and Quality of Life Outcomes, 10(1), 1–11. https://doi.org/10.1186/1477-7525-10-25CrossRef

51.

Donner-Banzhoff, N., & Hertwig, R. (2014). Inductive foraging: Improving the diagnostic yield of primary care consultations. European Journal of General Practice, 20(1), 69–73. https://doi.org/10.1370/afm.2264CrossRefPubMed

52.

Wilson, B., Lönnfors, S., Vermeire, S., Greco, M., Hommes, D., Bell, C., & Avedano, L. (2011). A European Crohn's and Ulcerative Colitis patient life IMPACT survey, 2010–2011. https://pdfs.semanticscholar.org/fe4a/190cae7f3d82dd0e8a9070f42f3329a8cb2d.pdf

53.

Karadag, P., Morris, B., & Woolfall, K. (2022). The information and support needs of patients living with inflammatory bowel disease: A qualitative study. Chronic Illness, 18(2), 356–369. https://doi.org/10.1177/1742395320968617CrossRefPubMed

54.

Zhao, J., Han, H., Zhong, B., Xie, W., Chen, Y., & Zhi, M. (2021). Health information on social media helps mitigate Crohn’s disease symptoms and improves patients’ clinical course. Computers in Human Behavior, 115, 106588. https://doi.org/10.1016/j.chb.2020.106588CrossRef

55.

Barello, S., Guida, E., Leone, S., Previtali, E., & Graffigna, G. (2021). Does patient engagement affect IBD patients’ health-related quality of life? Findings from a cross-sectional study among people with inflammatory bowel diseases. Health and Quality of Life Outcomes, 19, 1–9. https://doi.org/10.1186/s12955-021-01724-wCrossRef

56.

Ballering, A. V., Muijres, D., Uijen, A. A., Rosmalen, J. G., & olde Hartman, T. C. (2021). Sex differences in the trajectories to diagnosis of patients presenting with common somatic symptoms in primary care: An observational cohort study. Journal of Psychosomatic Research, 149, 110589. https://doi.org/10.1016/j.jpsychores.2021.110589CrossRefPubMed

57.

Van Langenberg, D. R., & Gibson, P. R. (2010). Systematic review: Fatigue in inflammatory bowel disease. Alimentary Pharmacology & Therapeutics, 32(2), 131–143. https://doi.org/10.1111/j.1365-2036.2010.04347.xCrossRef

58.

Locock, L., Nettleton, S., Kirkpatrick, S., Ryan, S., & Ziebland, S. (2016). ‘I knew before I was told’: Breaches, cues and clues in the diagnostic assemblage. Social Science & Medicine, 154, 85–92. https://doi.org/10.1016/j.socscimed.2016.02.037CrossRef

59.

Nguyen, G. C., Bouchard, S., & Diong, C. (2019). Promoting Access and Care through Centres of Excellence (PACE) Network. Access to specialists and emergency department visits in inflammatory bowel disease: A population-based study. Journal of Crohns & Colitis, 13, 330–336. https://doi.org/10.1093/ecco-jcc/jjy161CrossRef

60.

Angelberger, S., Vogelsang, H., Novacek, G., Miehsler, W., Dejaco, C., Gangl, A., & Reinisch, W. (2009). Public awareness of Crohn’s disease and ulcerative colitis: A national survey. Journal of Crohn’s & Colitis, 3(3), 157–161. https://doi.org/10.1016/j.crohns.2009.01.003CrossRef

61.

Bethune, R., Marshall, M. J., Mitchell, S. J., Oppong, C., Cartmel, M. T., Arumugam, P. J., Gee, A. S., & Daniels, I. R. (2013). Did the ‘Be Clear on Bowel Cancer’ public awareness campaign pilot result in a higher rate of cancer detection? Postgraduate Medical Journal, 89, 390–393. https://doi.org/10.1136/postgradmedj-2012-131014CrossRefPubMed

Titel: Understanding diagnostic delays and health outcomes for inflammatory bowel disease: a mixed-methods study of patients’ perspectives
Auteurs: R. J. Purc-Stephenson
Keely Blake
Publicatiedatum: 26-11-2024
Uitgeverij: Springer New York
Gepubliceerd in: Quality of Life Research
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI: https://doi.org/10.1007/s11136-024-03852-4

Bohn Stafleu van Loghum

Welkom bij THIM Hogeschool voor Fysiotherapie & Bohn Stafleu van Loghum

Registreer

Login

Understanding diagnostic delays and health outcomes for inflammatory bowel disease: a mixed-methods study of patients’ perspectives

Abstract

Purpose

Methods

Results

Conclusion

Bohn Stafleu van Loghum

Welkom bij THIM Hogeschool voor Fysiotherapie & Bohn Stafleu van Loghum

Registreer

Login

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Purpose

Methods

Results

Conclusion

Log in om toegang te krijgen